🎉🎉🎉Congratulations to Reviva Pharmaceuticals on the positive results from its Phase 3 open-label study of brilaroxazine, a novel investigational drug that showed effectiveness in treating both positive and negative symptoms of @schizophrenia. Learn more: (fb)

Mental Health Awareness Month ends tomorrow, but we’re working year round to advocate for people with #schizophrenia and #psychosis disorders and their caregivers. Frankly, we think setting aside just one month for schizophrenia trivializes the disease. How can that capture the totality of what people with schizophrenia endure? Real change happens when we are part of the conversation. We won’t rest until policymakers understand that we need equitable access to care. Until all providers have the resources they need to deliver high-quality care. Until everyone sees recovery as achievable. But we need your help to make that happen. Here are 5 reasons to make your gift today: 1. Our advocacy produces real results – such as the recent elimination of the clozapine REMS program. 2. Our support services are free to all (and our Resource Line is blowing up as the government chaos continues). 3. Our SPRING Summit activated new workstreams and built new pathways to take those actions forward. 4. We’re a small organization – yet we're going after some of the most complicated challenges this community faces. 5. We’ll be here for you through the storm and beyond – because you mean everything to us. In the words of a beloved community member: “You don't have to feel alone or isolated, because there's always hope.” Please take a moment to support our efforts: https://sczaction.org/donate/ (fb)